|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0020789,
umls-concept:C0030705,
umls-concept:C0085421,
umls-concept:C0086960,
umls-concept:C0201734,
umls-concept:C0205390,
umls-concept:C0278488,
umls-concept:C0442027,
umls-concept:C1274040,
umls-concept:C1880156,
umls-concept:C2603343
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-4-26
|
|
pubmed:abstractText |
To determine if protracted low-dose oral idarubicin (IDA), feasible in a previous dose-finding study, would result in similar activity and a better toxicity profile in patients with metastatic breast cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:CoronaGG,
pubmed-author:CrivellariDD,
pubmed-author:LestuzziCC,
pubmed-author:LombardiDD,
pubmed-author:LucenteMM,
pubmed-author:MagriM DMD,
pubmed-author:MassacesiCC,
pubmed-author:SmithG FGF,
pubmed-author:TalaminiRR,
pubmed-author:ToffoloAA,
pubmed-author:VeroneseMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
807-12
|
|
pubmed:meshHeading |
pubmed-meshheading:16497825-Administration, Oral,
pubmed-meshheading:16497825-Aged,
pubmed-meshheading:16497825-Aged, 80 and over,
pubmed-meshheading:16497825-Antibiotics, Antineoplastic,
pubmed-meshheading:16497825-Bone Neoplasms,
pubmed-meshheading:16497825-Breast Neoplasms,
pubmed-meshheading:16497825-Chromatography, High Pressure Liquid,
pubmed-meshheading:16497825-Daunorubicin,
pubmed-meshheading:16497825-Dose-Response Relationship, Drug,
pubmed-meshheading:16497825-Drug Administration Schedule,
pubmed-meshheading:16497825-Drug Monitoring,
pubmed-meshheading:16497825-Female,
pubmed-meshheading:16497825-Humans,
pubmed-meshheading:16497825-Idarubicin,
pubmed-meshheading:16497825-Liver Neoplasms,
pubmed-meshheading:16497825-Lung Neoplasms,
pubmed-meshheading:16497825-Soft Tissue Neoplasms
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring.
|
|
pubmed:affiliation |
Division of Medical Oncology C, Centro di Riferimento Oncologico, Aviano, Italy. dcrivellari@cro.it
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II
|
